Literature DB >> 7038335

Third generation cephalosporins.

B A Cunha, A M Ristuccia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7038335     DOI: 10.1016/s0025-7125(16)31460-2

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  11 in total

1.  Current antibiotic usage, I: Penicillins, cephalosporins and chloramphenicol.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

Review 2.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

Review 3.  New drugs in respiratory disorders: II.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

4.  Antibiotics I: new antibiotics and advances in antibiotic treatment.

Authors:  C R Pennington; J Crooks
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

5.  Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.

Authors:  R L Baker; R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Cefodizime penetration into skin suction blister fluid following a single intravenous dose.

Authors:  M Schäfer-Korting; H C Korting; L Maass; N Klesel; H G Grigoleit; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 8.  The cephalosporin antibiotics in pediatric therapy.

Authors:  H F Eichenwald; H J Schmitt
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 9.  Current guidelines on the use of antibacterial drugs in patients with malignancies.

Authors:  K H Mayer; O H DeTorres
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

10.  Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.

Authors:  J I Schwartz; L E Jauregui; K A Bachmann; M E Martin; D P Reitberg
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.